About PAREXEL International Corporation (NASDAQ:PRXL)
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology & Medical Research
- Sub-Industry: Life Sciences Tools & Services
- Symbol: NASDAQ:PRXL
- CUSIP: 69946210
- Web: www.parexel.com
- Market Cap: $4.5 billion
- Outstanding Shares: 51,115,000
- 50 Day Moving Avg: $87.85
- 200 Day Moving Avg: $79.27
- 52 Week Range: $51.16 - $88.10
Sales & Book Value:
- Trailing P/E Ratio: 42.76
- Foreward P/E Ratio: 19.53
- P/E Growth: 0.00
- Annual Revenue: $2.12 billion
- Price / Sales: 2.12
- Book Value: $12.42 per share
- Price / Book: 7.09
- EBITDA: $340.1 million
- Net Margins: 4.49%
- Return on Equity: 28.98%
- Return on Assets: 7.94%
- Debt-to-Equity Ratio: 1.01%
- Current Ratio: 1.45%
- Quick Ratio: 1.45%
- Average Volume: 839,481 shs.
- Beta: 0.77
- Short Ratio: 0.57
Frequently Asked Questions for PAREXEL International Corporation (NASDAQ:PRXL)
What is PAREXEL International Corporation's stock symbol?
PAREXEL International Corporation trades on the NASDAQ under the ticker symbol "PRXL."
How were PAREXEL International Corporation's earnings last quarter?
PAREXEL International Corporation (NASDAQ:PRXL) issued its earnings results on Monday, August, 28th. The company reported $1.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.08. The business earned $557.20 million during the quarter, compared to analysts' expectations of $537.59 million. PAREXEL International Corporation had a net margin of 4.49% and a return on equity of 28.98%. During the same quarter in the prior year, the business posted $0.94 EPS. View PAREXEL International Corporation's Earnings History.
When will PAREXEL International Corporation make its next earnings announcement?
Where is PAREXEL International Corporation's stock going? Where will PAREXEL International Corporation's stock price be in 2017?
12 equities research analysts have issued 12 month price objectives for PAREXEL International Corporation's shares. Their forecasts range from $53.00 to $88.10. On average, they expect PAREXEL International Corporation's share price to reach $73.71 in the next year. View Analyst Ratings for PAREXEL International Corporation.
Who are some of PAREXEL International Corporation's key competitors?
Some companies that are related to PAREXEL International Corporation include Ionis Pharmaceuticals (IONS), Alkermes PLC (ALKS), Qiagen N.V. (QGEN), Icon Plc (ICLR), Exact Sciences Corporation (EXAS), Charles River Laboratories International (CRL), United Therapeutics Corporation (UTHR), PRA Health Sciences (PRAH), Galapagos NV (GLPG), Bio-Techne Corp (TECH), Puma Biotechnology (PBYI), ACADIA Pharmaceuticals (ACAD), FibroGen (FGEN), Nektar Therapeutics (NKTR), WuXi PharmaTech (Cayman) (WX), INC Research Holdings (INCR), Ligand Pharmaceuticals Incorporated (LGND) and Portola Pharmaceuticals (PTLA).
Who are PAREXEL International Corporation's key executives?
PAREXEL International Corporation's management team includes the folowing people:
- Josef H. von Rickenbach, Chairman of the Board, Chief Executive Officer
- Mark A. Goldberg M.D., President, Chief Operating Officer
- Simon Harford, Chief Financial Officer, Senior Vice President
- Xavier AB Flinois, President - PAREXEL Informatics
- Michelle Graham, Chief Human Resource Officer, Senior Vice President
- Sybrand Pretorius M.D., Senior Vice President, Chief Scientific Officer
- Douglas Alexander Batt, Senior Vice President, General Counsel, Secretary
- Roland Andersson Ph.d., Senior Vice President - Clinical Research Services
- Christian Dreger Ph.D., Senior Vice President - Parexel Access and Parexel Consulting
- David J. Godwin, Senior Vice President-Global Business
Who owns PAREXEL International Corporation stock?
PAREXEL International Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include APG Asset Management N.V. (0.60%), Longfellow Investment Management Co. LLC (0.14%) and State Treasurer State of Michigan (0.04%). Company insiders that own PAREXEL International Corporation stock include A Dana Callow Jr, Eduard E Holdener, Gadi Saarony, Joshua Schultz, Patrick J Fortune, Richard L Love, Sybrand Pretorius and Ulf I Schneider. View Institutional Ownership Trends for PAREXEL International Corporation.
Who sold PAREXEL International Corporation stock? Who is selling PAREXEL International Corporation stock?
PAREXEL International Corporation's stock was sold by a variety of institutional investors in the last quarter, including State Treasurer State of Michigan. Company insiders that have sold PAREXEL International Corporation stock in the last year include Gadi Saarony and Sybrand Pretorius. View Insider Buying and Selling for PAREXEL International Corporation.
Who bought PAREXEL International Corporation stock? Who is buying PAREXEL International Corporation stock?
How do I buy PAREXEL International Corporation stock?
Shares of PAREXEL International Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is PAREXEL International Corporation's stock price today?
MarketBeat Community Rating for PAREXEL International Corporation (NASDAQ PRXL)MarketBeat's community ratings are surveys of what our community members think about PAREXEL International Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of PAREXEL International Corporation stock can currently be purchased for approximately $88.08.
Consensus Ratings for PAREXEL International Corporation (NASDAQ:PRXL) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 9 Hold Ratings, 2 Buy Ratings|
|Consensus Rating:||Hold (Score: 2.08)|
|Consensus Price Target: ||$73.71 (16.31% downside)|Consensus Price Target History for PAREXEL International Corporation (NASDAQ:PRXL)
Analysts' Ratings History for PAREXEL International Corporation (NASDAQ:PRXL)
(Data available from 10/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|6/21/2017||Jefferies Group LLC||Reiterated Rating||Hold||$88.10||Low|
|6/20/2017||Barclays PLC||Downgrade||Overweighr -> Equal Weight||$87.00||High|
|6/20/2017||Raymond James Financial, Inc.||Upgrade||Underperform -> Mkt Perform||High|
|6/6/2017||Credit Suisse Group||Reiterated Rating||Neutral||$65.00 -> $83.00||Low|
|5/30/2017||Mizuho||Boost Price Target||Buy -> Buy||$66.00 -> $75.00||Low|
|5/23/2017||Goldman Sachs Group, Inc. (The)||Upgrade||Sell -> Neutral||$63.00 -> $77.00||Low|
|5/15/2017||Evercore ISI||Upgrade||In-Line -> Outperform||$85.00||Low|
|2/3/2017||Deutsche Bank AG||Downgrade||Hold -> Sell||$66.00 -> $53.00||N/A|
|2/3/2017||Citigroup Inc.||Downgrade||Buy -> Neutral||N/A|
|11/23/2016||Wells Fargo & Company||Downgrade||Outperform -> Market Perform||N/A|
|11/17/2016||First Analysis||Downgrade||Overweight -> Equal Weight||$62.00||N/A|
|11/11/2016||SunTrust Banks, Inc.||Downgrade||Buy -> Hold||$80.00 -> $60.00||N/A|
|10/27/2016||Robert W. Baird||Downgrade||Outperform -> Neutral||$78.00 -> $67.00||N/A|
|7/18/2016||William Blair||Downgrade||Outperform -> Market Perform||N/A|
|4/11/2016||Avondale Partners||Lower Price Target||Underperform||$50.50 -> $49.00||N/A|
Earnings History for PAREXEL International Corporation (NASDAQ:PRXL)Earnings History by Quarter for PAREXEL International Corporation (NASDAQ PRXL)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/28/2017||Q4 2017||$0.94||$1.02||$537.59 million||$557.20 million||View||N/A|
|5/3/2017||Q3 2017||$0.73||$0.74||$529.38 million||$529.30 million||View||Listen|
|10/26/2016||Q117||$0.86||$0.76||$525.15 million||$500.90 million||View||Listen|
|8/3/2016||Q416||$0.93||$0.94||$532.41 million||$538.60 million||View||Listen|
|4/27/2016||Q316||$0.90||$0.89||$523.16 million||$527.10 million||View||Listen|
|1/27/2016||Q2||$0.72||$0.90||$523.03 million||$518.50 million||View||Listen|
|10/28/2015||Q116||$0.63||$0.70||$511.77 million||$512.10 million||View||Listen|
|8/5/2015||Q415||$0.74||$0.79||$527.13 million||$523.00 million||View||Listen|
|4/29/2015||Q315||$0.66||$0.66||$513.50 million||$502.03 million||View||Listen|
|1/28/2015||Q215||$0.60||$0.69||$502.20 million||$499.27 million||View||Listen|
|10/30/2014||Q115||$0.58||$0.65||$505.60 million||$491.69 million||View||Listen|
|8/7/2014||Q414||$0.62||$0.65||$508.99 million||$510.60 million||View||Listen|
|4/29/2014||Q314||$0.54||$0.56||$493.35 million||$492.40 million||View||Listen|
|1/30/2014||Q214||$0.49||$0.49||$479.49 million||$487.10 million||View||Listen|
|10/30/2013||Q114||$0.45||$0.45||$458.94 million||$449.20 million||View||Listen|
|8/7/2013||Q4 2013||$0.43||$0.50||$455.23 million||$463.10 million||View||Listen|
|4/30/2013||Q3 2013||$0.40||$0.50||$438.10 million||$454.49 million||View||Listen|
|1/29/2013||Q2 2013||$0.33||$0.41||$419.78 million||$422.10 million||View||Listen|
|10/30/2012||Q113||$0.29||$0.29||$396.70 million||$394.80 million||View||N/A|
Earnings Estimates for PAREXEL International Corporation (NASDAQ:PRXL)
2017 EPS Consensus Estimate: $3.73
2018 EPS Consensus Estimate: $3.86
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for PAREXEL International Corporation (NASDAQ:PRXL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for PAREXEL International Corporation (NASDAQ:PRXL)
Insider Ownership Percentage: 2.90%Insider Trades by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)
Institutional Ownership Percentage: 87.45%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/3/2017||Sybrand Pretorius||SVP||Sell||8,050||$65.12||$524,216.00|| |
|2/9/2017||Gadi Saarony||Insider||Sell||2,325||$64.54||$150,055.50|| |
|8/15/2016||Gadi Saarony||Insider||Sell||2,500||$70.05||$175,125.00|| |
|8/9/2016||Joshua Schultz||SVP||Sell||2,500||$68.64||$171,600.00|| |
|6/13/2016||A Dana Callow Jr||Director||Sell||3,000||$60.04||$180,120.00|| |
|6/2/2016||Eduard E Holdener||Director||Sell||700||$62.98||$44,086.00|| |
|5/25/2016||Ulf I Schneider||SVP||Sell||7,500||$62.00||$465,000.00|| |
|5/24/2016||Ulf I Schneider||SVP||Sell||6,000||$61.00||$366,000.00|| |
|5/23/2016||Ulf I Schneider||SVP||Sell||6,000||$60.01||$360,060.00|| |
|5/20/2016||Ulf I Schneider||SVP||Sell||8,000||$59.24||$473,920.00|| |
|3/30/2016||Richard L Love||Director||Sell||1,330||$62.50||$83,125.00|| |
|12/1/2015||Richard L Love||Director||Sell||1,330||$68.21||$90,719.30|| |
|11/24/2015||Eduard E Holdener||Director||Sell||2,200||$67.66||$148,852.00|| |
|11/12/2015||Gadi Saarony||SVP||Sell||12,425||$67.01||$832,599.25|| |
|11/11/2015||Patrick J Fortune||Director||Sell||1,500||$68.07||$102,105.00|| |
|9/1/2015||Richard L Love||Director||Sell||1,330||$64.26||$85,465.80|| |
|8/18/2015||Mark A Goldberg||COO||Sell||8,995||$73.49||$661,042.55|| |
|8/18/2015||Thomas Senderovitz||SVP||Sell||1,500||$74.02||$111,030.00|| |
|6/18/2015||Mark A Goldberg||COO||Sell||11,507||$70.03||$805,835.21|| |
|5/14/2015||Richard L Love||Director||Sell||5,000||$65.00||$325,000.00|| |
|3/19/2015||Mark A Goldberg||COO||Sell||12,884||$68.99||$888,867.16|| |
|3/2/2015||A Dana Callow Jr||Director||Sell||2,000||$65.84||$131,680.00|| |
|2/19/2015||Christopher J Lindop||Director||Sell||2,000||$63.59||$127,180.00|| |
|2/13/2015||Rickenbach Josef H Von||CEO||Sell||65,100||$62.53||$4,070,703.00|| |
|2/6/2015||Eduard E Holdener||Director||Sell||3,000||$62.97||$188,910.00|| |
|2/4/2015||Douglas A Batt||SVP||Sell||8,300||$60.89||$505,387.00|| |
|2/3/2015||Gadi Saarony||VP||Sell||8,525||$60.97||$519,769.25|| |
|12/3/2014||Mark A Goldberg||COO||Sell||25,345||$58.99||$1,495,101.55|| |
|11/5/2014||Christopher J Lindop||Director||Sell||12,000||$55.00||$660,000.00|| |
|8/20/2014||Gadi Saarony||VP||Sell||6,075||$57.78||$351,013.50|| |
|8/18/2014||Anita Cooper||VP||Sell||4,916||$57.56||$282,964.96|| |
|8/15/2014||Anita Cooper||VP||Sell||5,084||$57.50||$292,330.00|| |
|8/14/2014||Anita Cooper||VP||Sell||6,800||$57.54||$391,272.00|| |
|8/13/2014||Mark A Goldberg||COO||Sell||16,761||$56.33||$944,147.13|| |
|8/11/2014||Richard L Love||Director||Sell||6,000||$57.33||$343,980.00|| |
|6/5/2014||Patrick J Fortune||Director||Sell||3,000||$53.04||$159,120.00|| |
|2/20/2014||Anita Cooper||VP||Sell||2,500||$53.00||$132,500.00|| |
|2/18/2014||Mark Goldberg||COO||Sell||11,206||$52.49||$588,202.94|| |
|2/12/2014||Mark Goldberg||COO||Sell||12,199||$50.49||$615,927.51|| |
|2/11/2014||Anita Cooper||VP||Sell||10,000||$50.00||$500,000.00|| |
|2/10/2014||Eduard Holdener||Director||Sell||6,000||$49.62||$297,720.00|| |
|2/10/2014||Rickenbach Josef Von||CEO||Sell||50,000||$49.76||$2,488,000.00|| |
|2/7/2014||Gadi Saarony||VP||Sell||9,950||$49.56||$493,122.00|| |
|2/7/2014||Rickenbach Josef Von||CEO||Sell||50,000||$49.70||$2,485,000.00|| |
|2/4/2014||Christopher Lindop||Director||Sell||10,000||$49.00||$490,000.00|| |
|2/3/2014||Douglas Batt||SVP||Sell||8,000||$48.58||$388,640.00|| |
|2/3/2014||Mark Goldberg||COO||Sell||13,529||$48.70||$658,862.30|| |
|1/13/2014||Mark Goldberg||COO||Sell||6,957||$48.90||$340,197.30|| |
|1/9/2014||Mark Goldberg||COO||Sell||6,901||$46.49||$320,827.49|| |
|12/12/2013||Xavier Flinois||Insider||Buy||5,000||$41.11||$205,550.00|| |
|9/11/2013||Patrick Fortune||Director||Sell||7,000||$48.31||$338,170.00|| |
|8/28/2013||Richard Love||Director||Sell||5,000||$47.04||$235,200.00|| |
|6/4/2013||Douglas A Batt||SVP||Sell||15,000||$45.15||$677,250.00|| |
|6/3/2013||Mark A Goldberg||COO||Sell||15,000||$45.06||$675,900.00|| |
|5/20/2013||Richard L Love||Director||Sell||8,000||$46.65||$373,200.00|| |
|5/14/2013||A Dana Callow Jr||Director||Sell||8,000||$46.39||$371,120.00|| |
|5/13/2013||Mark A Goldberg||COO||Sell||28,887||$45.19||$1,305,403.53|| |
|5/10/2013||Anita Cooper||VP||Sell||10,000||$44.99||$449,900.00|| |
|5/9/2013||Ulf I Schneider||SVP||Sell||20,510||$44.54||$913,515.40|| |
|10/4/2012||Mark A Goldberg||COO||Sell||5,000||$32.00||$160,000.00|| |
Headline Trends for PAREXEL International Corporation (NASDAQ:PRXL)
Latest Headlines for PAREXEL International Corporation (NASDAQ:PRXL)
Loading headlines, please wait.
PAREXEL International Corporation (PRXL) Chart for Monday, October, 23, 2017